Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery
Emulate official blog RSS · 行业原文收录 · 来源发布：Wed Aug 27 2025 20:53:46 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 07:04:42 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models has never been greater. That’s why Emulate recently launched the AVA Emulation System , the first self-contained Organ-on-a-Chip workstation designed to bring scale, reproducibility, and accessibility to this
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。